Kymera Results Presentation Deck

KYMERA 7 # of Patients by AD-IGA Score N + 0 ● Investigator's Global Assessment (VIGA-AD) 2 4 1 Baseline VIGA-AD Score Over Time (n=7) Ⓒ2022 KYMERA THERAPEUTICS, INC. 1 4 2 Day 14 1 4 2 Day 28 ■Mild Moderate Severe IGA scores remained stable or improved in all patients 1 4 2 Day 35 1 3 3 Day 42 PAGE 48

View entire presentation